Slide background
INNOVATING targeting
Slide background
INNOVATING targeting


Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation ... Read all


Philogen is pleased to announce that it has signed a collaborative agreement with Boehringer Ingelheim to investigate novel treatment approaches for Acute Myeloid Leukemia. Siena (Italy), October 12th. (see full Press...

Read all


Philogen is a fully integrated company active in the discovery, GMP production and clinical development of immunomodulatory biopharmaceuticals. We have a leading position in the field of antibody-based therapeutics ... Read all


Boehringer Ingelheim
Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.